Organization
Ever Neuro Pharma
4 clinical trials
Clinical trial
C-REGS2 - A Registry Study to Observe Clinical Practices, Safety and Efficiency of Routine Use of Cerebrolysin in the Treatment of Patients With Moderate to Severe Neurological Deficits After Acute Ischaemic StrokeStatus: Recruiting, Estimated PCD: 2024-04-15
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic StrokeStatus: Completed, Estimated PCD: 2010-10-01
Clinical trial
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular DementiaStatus: Completed
Clinical trial
A Randomized, Double-blind, Single-centre, Two-period Cross-over, Placebo-controlled Trial on Safety and Efficacy in Patients With Genetically Proven CADASILStatus: Recruiting, Estimated PCD: 2026-03-31